+++
draft = false
abstract = "We describe a cost-effective, scalable technology to produce SARS-COV-2 spike (S) protein based on stable expression in HEK293 cells, and its use to develop a highly specific and sensitive ELISA test. The assay allows early detection of anti-S IgG seroconversion and endpoint titers correlate with virus neutralization. The low-cost S-antigen production, together with sample collection by finger prick and dried blood spots, allowed the development of a half-dollar test that fits the urgent need for large-scale serological surveillance in low-income countries."
abstract_short = ""
authors = ["Renata G. F. Alvim", "Tulio M. Lima", "Danielle A. S. Rodrigues", "Federico F. Marsili", "Vicente B.T. Bozza", "Luiza M. Higa", "Fabio L. Monteiro", "Isabela C. Leitao", "Renato S. Carvalho", "Rafael M. Galliez", "Terezinha M. P. P. Castineiras", "Alberto Nobrega", "Leonardo H. Travassos", "Orlando C. Ferreira Jr.", "Amilcar Tanuri", "Andre M. Vale", "Leda R. Castilho"]
date = "2020-07-15"
image = ""
image_preview = ""
math = false
publication = ""
publication_preprint = "medrxiv"
publication_short = ""
title = "AN AFFORDABLE ANTI-SARS-COV-2 SPIKE ELISA TEST FOR EARLY DETECTION OF IgG SEROCONVERSION SUITED FOR LARGE-SCALE SURVEILLANCE STUDIES IN LOW-INCOME COUNTRIES"
doi = "10.1101/2020.07.13.20152884"
url_code = ""
url_dataset = ""
url_pdf = "http://medrxiv.org/cgi/content/short/2020.07.13.20152884.full.pdf"
url_project = ""
url_slides = ""
url_video = ""
+++